These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9578549

  • 21. Stopped-flow kinetic investigations of conformational changes of pig kidney Na+,K+-ATPase.
    Kane DJ, Fendler K, Grell E, Bamberg E, Taniguchi K, Froehlich JP, Clarke RJ.
    Biochemistry; 1997 Oct 28; 36(43):13406-20. PubMed ID: 9341234
    [Abstract] [Full Text] [Related]

  • 22. Cryptosin induces backbone structural changes in cardiac Na+ and K+ dependent adenosinetriphosphatase.
    Venkateswara RR, Dipak D, Banning JW, Vaidyanathan CS.
    Biochem Int; 1990 Oct 28; 22(2):287-94. PubMed ID: 1965277
    [Abstract] [Full Text] [Related]

  • 23. Competitive inhibition of (Na/K)-ATPase by furylethylenes with respect to potassium ions.
    Breier A, Vrbanová A, Docolomanský P, Bohácová V, Ziegelhöffer A.
    Gen Physiol Biophys; 1996 Aug 28; 15(4):291-307. PubMed ID: 9088927
    [Abstract] [Full Text] [Related]

  • 24. Ouabain interactions with the H5-H6 hairpin of the Na,K-ATPase reveal a possible inhibition mechanism via the cation binding domain.
    Palasis M, Kuntzweiler TA, Argüello JM, Lingrel JB.
    J Biol Chem; 1996 Jun 14; 271(24):14176-82. PubMed ID: 8662895
    [Abstract] [Full Text] [Related]

  • 25. E2P phosphoforms of Na,K-ATPase. II. Interaction of substrate and cation-binding sites in Pi phosphorylation of Na,K-ATPase.
    Cornelius F, Fedosova NU, Klodos I.
    Biochemistry; 1998 Nov 24; 37(47):16686-96. PubMed ID: 9843437
    [Abstract] [Full Text] [Related]

  • 26. Heterogeneity of Na,K-ATPase from kidney.
    Hansen O.
    Acta Physiol Scand Suppl; 1992 Nov 24; 607():229-34. PubMed ID: 1333154
    [Abstract] [Full Text] [Related]

  • 27. The hydrogen bonds between Arg423 and Glu472 and other key residues, Asp443, Ser477, and Pro489, are responsible for the formation and a different positioning of TNP-ATP and ATP within the nucleotide-binding site of Na(+)/K(+)-ATPase.
    Lánský Z, Kubala M, Ettrich R, Kutý M, Plásek J, Teisinger J, Schoner W, Amler E.
    Biochemistry; 2004 Jul 06; 43(26):8303-11. PubMed ID: 15222743
    [Abstract] [Full Text] [Related]

  • 28. Preparation of Na,K-ATPase specifically modified on the anti-fluorescein antibody-inaccessible site by fluorescein 5'-isothiocyanate.
    Lin SH, Faller LD.
    Anal Biochem; 2000 Dec 15; 287(2):303-12. PubMed ID: 11112278
    [Abstract] [Full Text] [Related]

  • 29. Estimation of the distance change between cysteine-457 and the nucleotide binding site when sodium pump changes conformation from E1 to E2 by fluorescence energy transfer measurements.
    Lin SH, Faller LD.
    Biochemistry; 1996 Jun 25; 35(25):8419-28. PubMed ID: 8679600
    [Abstract] [Full Text] [Related]

  • 30. TNP-8N3-ADP photoaffinity labeling of two Na,K-ATPase sequences under separate Na+ plus K+ control.
    Ward DG, Taylor M, Lilley KS, Cavieres JD.
    Biochemistry; 2006 Mar 14; 45(10):3460-71. PubMed ID: 16519541
    [Abstract] [Full Text] [Related]

  • 31. Elucidation of the Na+, K+-ATPase digitalis binding site.
    Keenan SM, DeLisle RK, Welsh WJ, Paula S, Ball WJ.
    J Mol Graph Model; 2005 Jun 14; 23(6):465-75. PubMed ID: 15886034
    [Abstract] [Full Text] [Related]

  • 32. Fluorescence energy transfer studies of human deoxycytidine kinase: role of cysteine 185 in the conformational changes that occur upon substrate binding.
    Mani RS, Usova EV, Cass CE, Eriksson S.
    Biochemistry; 2006 Mar 21; 45(11):3534-41. PubMed ID: 16533034
    [Abstract] [Full Text] [Related]

  • 33. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids.
    Pullen MA, Brooks DP, Edwards RM.
    J Pharmacol Exp Ther; 2004 Jul 21; 310(1):319-25. PubMed ID: 14982968
    [Abstract] [Full Text] [Related]

  • 34. Stimulation of ouabain binding to Na,K-ATPase in 40% dimethyl sulfoxide by a factor from Na,K-ATPase preparations.
    Fontes CF, Lopes FE, Scofano HM, Barrabin H, Norby JG.
    Arch Biochem Biophys; 1999 Jun 15; 366(2):215-23. PubMed ID: 10356286
    [Abstract] [Full Text] [Related]

  • 35. High affinity anti-digoxin antibodies as model receptors for cardiac glycosides. Comparisons with Na+,K(+)-ATPase.
    Kasturi R, McLean LR, Margolies MN, Ball WJ.
    Ann N Y Acad Sci; 1997 Nov 03; 834():634-6. PubMed ID: 9405877
    [No Abstract] [Full Text] [Related]

  • 36. Kinetic analysis of ouabain binding to native and mutated forms of Na,K-ATPase and identification of a new region involved in cardiac glycoside interactions.
    Schultheis PJ, Wallick ET, Lingrel JB.
    J Biol Chem; 1993 Oct 25; 268(30):22686-94. PubMed ID: 8226778
    [Abstract] [Full Text] [Related]

  • 37. D443 of the N domain of Na+,K+-ATPase interacts with the ATP-Mg2+ complex, possibly via a second Mg2+ ion.
    Strugatsky D, Gottschalk KE, Goldshleger R, Karlish SJ.
    Biochemistry; 2005 Dec 13; 44(49):15961-9. PubMed ID: 16331955
    [Abstract] [Full Text] [Related]

  • 38. Solubilization of a complex of tryptic fragments of Na,K-ATPase containing occluded Rb ions and bound ouabain.
    Or E, Goldshleger ED, Tal DM, Karlish SJ.
    Biochemistry; 1996 May 28; 35(21):6853-64. PubMed ID: 8639637
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cation and cardiac glycoside binding sites of the Na,K-ATPase.
    Lingrel JB, Argüello JM, Van Huysse J, Kuntzweiler TA.
    Ann N Y Acad Sci; 1997 Nov 03; 834():194-206. PubMed ID: 9405808
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.